KR890004123B1 - 스트렙토콕커스 뮤탄스에 의한 유발된 충치억제용 항체의 제조방법 - Google Patents

스트렙토콕커스 뮤탄스에 의한 유발된 충치억제용 항체의 제조방법 Download PDF

Info

Publication number
KR890004123B1
KR890004123B1 KR1019840004419A KR840004419A KR890004123B1 KR 890004123 B1 KR890004123 B1 KR 890004123B1 KR 1019840004419 A KR1019840004419 A KR 1019840004419A KR 840004419 A KR840004419 A KR 840004419A KR 890004123 B1 KR890004123 B1 KR 890004123B1
Authority
KR
South Korea
Prior art keywords
mutans
strain
antibody
antigen
streptococcus mutans
Prior art date
Application number
KR1019840004419A
Other languages
English (en)
Korean (ko)
Other versions
KR850000982A (ko
Inventor
다가시 쭈루미즈
다가시 하시모도
Original Assignee
기다사노 겐큐쇼
미즈노에 고오에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기다사노 겐큐쇼, 미즈노에 고오에이 filed Critical 기다사노 겐큐쇼
Publication of KR850000982A publication Critical patent/KR850000982A/ko
Application granted granted Critical
Publication of KR890004123B1 publication Critical patent/KR890004123B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1019840004419A 1983-07-25 1984-07-25 스트렙토콕커스 뮤탄스에 의한 유발된 충치억제용 항체의 제조방법 KR890004123B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58-135451 1983-07-03
JP58135451A JPS6028937A (ja) 1983-07-25 1983-07-25 非う蝕性抗体および組成物

Publications (2)

Publication Number Publication Date
KR850000982A KR850000982A (ko) 1985-03-14
KR890004123B1 true KR890004123B1 (ko) 1989-10-21

Family

ID=15152017

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004419A KR890004123B1 (ko) 1983-07-25 1984-07-25 스트렙토콕커스 뮤탄스에 의한 유발된 충치억제용 항체의 제조방법

Country Status (5)

Country Link
JP (1) JPS6028937A (de)
KR (1) KR890004123B1 (de)
AU (1) AU3088984A (de)
DE (1) DE3427477A1 (de)
GB (1) GB2143829B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659561A (en) * 1983-02-18 1987-04-21 The University Of Vermont And State Agricultural College Process for treating the oral cavity
JPH01250067A (ja) * 1988-03-30 1989-10-05 Lion Corp ストレプトコッカス・・ミユータンスの検出方法
SE9701026D0 (sv) * 1997-03-20 1997-03-20 Immun System Ims Ab use of avian antibodies
AU2000270698A1 (en) * 2000-08-24 2002-03-04 Regents Of The Universtiy Of California Immunologic method for the prevention of dental caries
KR100425009B1 (ko) * 2000-11-01 2004-04-03 제노백(주) 스트렙토코쿠스 뮤탄스 균주에 의한 충치 예방용 항원 및항체의 제조 방법
KR20020056612A (ko) * 2000-12-29 2002-07-10 이남형 스트랩토코커스 뮤탄스, 스트랩토코커스 상기스,액티노마이세스 이스라엘리에 대한 특수 면역단백질을함유한 계란생산방법, 상기 생산방법으로 생산된 계란 및난황, 그리고 항 구강질환 특수 면역단백질 및 그면역단백질을 함유한 아이스크림
KR100479735B1 (ko) * 2002-05-25 2005-03-30 이현철 대식세포특이 나노입자-면역조절제-면역원 복합체를이용한 치아우식증을 예방하는 비경구용 백신
US7875598B2 (en) 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
CA2957056A1 (en) 2006-09-06 2008-03-13 C3 Jian, Inc. Selectively targeted antimicrobial peptides and the use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
GB2033223B (en) * 1978-09-01 1983-09-14 Secr Social Service Brit Antigen fromstreptococcus mutans for protection against dental caries
JPS56501364A (de) * 1979-10-18 1981-09-24
GB2060647B (en) * 1979-10-18 1983-04-13 Russell M W Antigens ex streptococcus mutans
AU556184B2 (en) * 1981-06-19 1986-10-23 Secretary of State For Social Services in Her Britanic Majestys Government of the United Kingdom of Great Britain and Northern Ireland Protection against dental caries.

Also Published As

Publication number Publication date
DE3427477C2 (de) 1988-11-17
DE3427477A1 (de) 1985-06-05
AU3088984A (en) 1985-01-31
GB2143829A (en) 1985-02-20
GB8418916D0 (en) 1984-08-30
GB2143829B (en) 1987-10-28
KR850000982A (ko) 1985-03-14
JPS6028937A (ja) 1985-02-14
JPH0463864B2 (de) 1992-10-13

Similar Documents

Publication Publication Date Title
De Soet et al. Differences in cariogenicity between fresh isolates of Streptococcus sobrinus and Streptococcus mutans
US4661350A (en) Dental vaccine for inhibiting periodontitis
EP0088303A2 (de) Verfahren zur Herstellung von Polysaccharid-Protein-Komplexen aus Bakterienhüllen, die hergestellten Produkte und dieselben enthaltende immunogenische Zusammensetzungen
KR890004123B1 (ko) 스트렙토콕커스 뮤탄스에 의한 유발된 충치억제용 항체의 제조방법
Tanzer et al. Variable experiences in immunization of rats against Streptococcus mutans-associated dental caries
Roos et al. Acute bacterial meningitis
Smith et al. Effects of local immunization with glucosyltransferase fractions from Streptococcus mutans on dental caries in hamsters caused by homologous and heterologous serotypes of Streptococcus mutans
US5240704A (en) Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans
US4731245A (en) Vaccine, antigen and antibody for treating microorganisms of the MCLS-type streptococcus sanguis
Guentzel et al. Animal models for candidiasis
KR890004103B1 (ko) 치주염 억제용 항체의 제조방법
Cheng et al. Enteric bacteria as a possible cause of hemolytic antibody-forming cells in normal mouse spleens.
KR20020079238A (ko) 항비듬균 면역항체와 그 용도
EP0048881B1 (de) Immunisierung von Menschen gegen enterotoxogenische Infektionen durch Escherichia Coli
US5281524A (en) Cell-associated glucosyltransferase from Streptococcus mutans serotype, c, e or f
US5135739A (en) Non-cariogenic composition and drink
EP0090617B1 (de) Vakzin für den Schutz oder die Hemmung von durch kartogenisches Streptococcus mutans induzierter menschlicher Zahnfäule
Gibbons et al. Virulence-related physiological changes and antigenic variation in populations of Streptococcus mutans colonizing gnotobiotic rats
JP2666214B2 (ja) 抗体およびそれを有効成分とする齲蝕予防剤の製造方法
JP2666211B2 (ja) 抗体およびそれを有効成分とする齲蝕予防剤の製造方法
US20040126384A1 (en) Combination of IgY against dental caries
KR890003942B1 (ko) 스트렙토코쿠스 상기스의 mcls형 미생물 처리용 항체의 제조방법
JP2657787B2 (ja) 虫歯予防用ワクチンの製法
JPS6064930A (ja) 虫歯用ワクチン
JPH0826079B2 (ja) 抗体及びそれを有効成分とするう蝕予防組成物

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
O035 Opposition [patent]: request for opposition

Free format text: OPPOSITION NUMBER: 001989000010; OPPOSITION DATE: 19891220

E701 Decision to grant or registration of patent right
O073 Decision to grant registration after opposition [patent]: decision to grant registration
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19931012

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee